PROSTATE CANCER STAGE II

PROSTATE CANCER STAGE II was reported 3090 times

PROSTATE CANCER STAGE II is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SLAMF7-directed Immunostimulatory Antibody [EPC] 4 0.0008
1 Interferon gamma [EPC] 1 0.0007
2 Provitamin D2 Compound [EPC] 6 0.0002
3 Allylamine Antifungal [EPC] 1 0.0001
4 Interleukin-17A Antagonist [EPC] 4 0.0001
5 Androgen [EPC] 2 0.0001
6 Interleukin-23 Antagonist [EPC] 7 0.0001
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
8 Integrin Receptor Antagonist [EPC] 5 0.0001
9 Nitrofuran Antibacterial [EPC] 1 0.0001
10 Interferon beta [EPC] 10 0.0001
11 5-alpha Reductase Inhibitor [EPC] 5 0.0000
12 Phosphodiesterase 5 Inhibitor [EPC] 6 0.0000
13 Thalidomide Analog [EPC] 22 0.0000
14 Cardiac Glycoside [EPC] 3 0.0000
15 Prostacyclin Receptor Agonist [EPC] 1 0.0000
16 Macrolide Antimicrobial [EPC] 2 0.0000
17 Sympathomimetic-like Agent [EPC] 1 0.0000
18 Fluoroquinolone Antibacterial [EPC] 4 0.0000
19 Interleukin-12 Antagonist [EPC] 3 0.0000
20 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
21 Proteasome Inhibitor [EPC] 3 0.0000
22 Angiotensin 2 Receptor Blocker [EPC] 8 0.0000
23 Anti-IgE [EPC] 2 0.0000
24 gamma-Aminobutyric Acid-ergic Agonist [EPC] 2 0.0000
25 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
26 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
27 Expectorant [EPC] 4 0.0000
28 Thiazide Diuretic [EPC] 4 0.0000
29 Proton Pump Inhibitor [EPC] 11 0.0000
30 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
31 Vitamin B12 [EPC] 6 0.0000
32 Platelet Aggregation Inhibitor [EPC] 10 0.0000
33 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
34 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
35 Vitamin D [EPC] 5 0.0000
36 BCL-2 Inhibitor [EPC] 1 0.0000
37 Corticosteroid [EPC] 20 0.0000
38 Vitamin C [EPC] 6 0.0000
39 Tetracycline-class Drug [EPC] 1 0.0000
40 Potassium Channel Blocker [EPC] 1 0.0000
41 Folate Analog Metabolic Inhibitor [EPC] 6 0.0000
42 Androgen Receptor Inhibitor [EPC] 1 0.0000
43 HMG-CoA Reductase Inhibitor [EPC] 5 0.0000
44 Azole Antifungal [EPC] 2 0.0000
45 Alkylating Drug [EPC] 3 0.0000
46 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
47 Nonsteroidal Anti-inflammatory Drug [EPC] 15 0.0000
48 Nitrate Vasodilator [EPC] 1 0.0000
49 Loop Diuretic [EPC] 5 0.0000
50 Osmotic Laxative [EPC] 3 0.0000
51 Purine Antimetabolite [EPC] 1 0.0000
52 Aminosalicylate [EPC] 1 0.0000
53 Antirheumatic Agent [EPC] 1 0.0000
54 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
55 Dihydropyridine Calcium Channel Blocker [EPC] 3 0.0000
56 Parathyroid Hormone Analog [EPC] 1 0.0000
57 Sulfonylurea [EPC] 1 0.0000
58 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
59 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
60 alpha-Adrenergic Blocker [EPC] 1 0.0000
61 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
62 Calcium [EPC] 1 0.0000
63 beta-Adrenergic Blocker [EPC] 2 0.0000
64 Aldosterone Antagonist [EPC] 1 0.0000
65 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
66 Janus Kinase Inhibitor [EPC] 1 0.0000
67 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
68 Benzodiazepine [EPC] 4 0.0000
69 Endothelin Receptor Antagonist [EPC] 1 0.0000
70 Interleukin-4 Receptor alpha Antagonist [EPC] 2 0.0000
71 Opioid Agonist [EPC] 1 0.0000
72 Factor Xa Inhibitor [EPC] 1 0.0000
73 Kinase Inhibitor [EPC] 2 0.0000
74 GLP-1 Receptor Agonist [EPC] 1 0.0000
75 Insulin Analog [EPC] 1 0.0000